BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 16123129)

  • 1. Interferon function is not required for recovery from a secondary poxvirus infection.
    Panchanathan V; Chaudhri G; Karupiah G
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12921-6. PubMed ID: 16123129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Poxvirus-encoded gamma interferon binding protein dampens the host immune response to infection.
    Sakala IG; Chaudhri G; Buller RM; Nuara AA; Bai H; Chen N; Karupiah G
    J Virol; 2007 Apr; 81(7):3346-53. PubMed ID: 17229697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlates of protective immunity in poxvirus infection: where does antibody stand?
    Panchanathan V; Chaudhri G; Karupiah G
    Immunol Cell Biol; 2008 Jan; 86(1):80-6. PubMed ID: 17923850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Obligatory requirement for antibody in recovery from a primary poxvirus infection.
    Chaudhri G; Panchanathan V; Bluethmann H; Karupiah G
    J Virol; 2006 Jul; 80(13):6339-44. PubMed ID: 16775322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective immunity against secondary poxvirus infection is dependent on antibody but not on CD4 or CD8 T-cell function.
    Panchanathan V; Chaudhri G; Karupiah G
    J Virol; 2006 Jul; 80(13):6333-8. PubMed ID: 16775321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redundant Function of Plasmacytoid and Conventional Dendritic Cells Is Required To Survive a Natural Virus Infection.
    Kaminsky LW; Sei JJ; Parekh NJ; Davies ML; Reider IE; Krouse TE; Norbury CC
    J Virol; 2015 Oct; 89(19):9974-85. PubMed ID: 26202250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TNF deficiency dysregulates inflammatory cytokine production, leading to lung pathology and death during respiratory poxvirus infection.
    Tuazon Kels MJ; Ng E; Al Rumaih Z; Pandey P; Ruuls SR; Korner H; Newsome TP; Chaudhri G; Karupiah G
    Proc Natl Acad Sci U S A; 2020 Jul; 117(27):15935-15946. PubMed ID: 32571912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunopathogenesis of poxvirus infections: forecasting the impending storm.
    Stanford MM; McFadden G; Karupiah G; Chaudhri G
    Immunol Cell Biol; 2007; 85(2):93-102. PubMed ID: 17228320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of interferon and interferon regulatory factors in early protection against Venezuelan equine encephalitis virus infection.
    Grieder FB; Vogel SN
    Virology; 1999 Apr; 257(1):106-18. PubMed ID: 10208925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine interferon lambdas (type III interferons) exhibit potent antiviral activity in vivo in a poxvirus infection model.
    Bartlett NW; Buttigieg K; Kotenko SV; Smith GL
    J Gen Virol; 2005 Jun; 86(Pt 6):1589-1596. PubMed ID: 15914836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection.
    Samuelsson C; Hausmann J; Lauterbach H; Schmidt M; Akira S; Wagner H; Chaplin P; Suter M; O'Keeffe M; Hochrein H
    J Clin Invest; 2008 May; 118(5):1776-84. PubMed ID: 18398511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated cytotoxicity in recovery from poxvirus infections.
    Müllbacher A
    Rev Med Virol; 2003; 13(4):223-32. PubMed ID: 12820184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Propagation and Purification of Ectromelia Virus.
    Chaudhri G; Kaladimou G; Pandey P; Karupiah G
    Curr Protoc Microbiol; 2018 Nov; 51(1):e65. PubMed ID: 30281950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The efficacy of cidofovir treatment of mice infected with ectromelia (mousepox) virus encoding interleukin-4.
    Robbins SJ; Jackson RJ; Fenner F; Beaton S; Medveczky J; Ramshaw IA; Ramsay AJ
    Antiviral Res; 2005 Apr; 66(1):1-7. PubMed ID: 15781125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-inducible chemokines and immunity to poxvirus infections.
    Mahalingam S; Foster PS; Lobigs M; Farber JM; Karupiah G
    Immunol Rev; 2000 Oct; 177():127-33. PubMed ID: 11138770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poxvirus-encoded serpins do not prevent cytolytic T cell-mediated recovery from primary infections.
    Müllbacher A; Wallich R; Moyer RW; Simon MM
    J Immunol; 1999 Jun; 162(12):7315-21. PubMed ID: 10358181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models for studying orthopoxvirus respiratory infections.
    Schriewer J; Buller RM; Owens G
    Methods Mol Biol; 2004; 269():289-308. PubMed ID: 15114022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ectromelia virus: the causative agent of mousepox.
    Esteban DJ; Buller RML
    J Gen Virol; 2005 Oct; 86(Pt 10):2645-2659. PubMed ID: 16186218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Animal models of orthopoxvirus infection.
    Chapman JL; Nichols DK; Martinez MJ; Raymond JW
    Vet Pathol; 2010 Sep; 47(5):852-70. PubMed ID: 20682806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of distinct poxvirus infections on the specificities and functionalities of CD4+ T cell responses.
    Siciliano NA; Hersperger AR; Lacuanan AM; Xu RH; Sidney J; Sette A; Sigal LJ; Eisenlohr LC
    J Virol; 2014 Sep; 88(17):10078-91. PubMed ID: 24965457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.